On Monday, Ensysce Biosciences Inc (NASDAQ: ENSC) opened lower -5.94% from the last session, before settling in for the closing price of $0.35. Price fluctuations for ENSC have ranged from $0.14 to $2.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -10.06% annually for the last half of the decade. Company’s average yearly earnings per share was noted 76.33% at the time writing. With a float of $14.52 million, this company’s outstanding shares have now reached $14.91 million.
In an organization with 9 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -338.26%, operating margin of -671.9%, and the pretax margin is -784.43%.
Ensysce Biosciences Inc (ENSC) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ensysce Biosciences Inc is 2.64%, while institutional ownership is 3.35%.
Ensysce Biosciences Inc (ENSC) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.87 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.06) by 0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.33% per share during the next fiscal year.
Ensysce Biosciences Inc (NASDAQ: ENSC) Trading Performance Indicators
Check out the current performance indicators for Ensysce Biosciences Inc (ENSC). In the past quarter, the stock posted a quick ratio of 1.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.76, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Ensysce Biosciences Inc (ENSC)
Let’s dig in a bit further. During the last 5-days, its volume was 154.28 million. That was better than the volume of 4.86 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 27.86%. Additionally, its Average True Range was 0.08.
During the past 100 days, Ensysce Biosciences Inc’s (ENSC) raw stochastic average was set at 28.16%, which indicates a significant increase from 28.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 443.18% in the past 14 days, which was higher than the 203.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3199, while its 200-day Moving Average is $0.6197. However, in the short run, Ensysce Biosciences Inc’s stock first resistance to watch stands at $0.3757. Second resistance stands at $0.4186. The third major resistance level sits at $0.4402. If the price goes on to break the first support level at $0.3112, it is likely to go to the next support level at $0.2896. The third support level lies at $0.2467 if the price breaches the second support level.
Ensysce Biosciences Inc (NASDAQ: ENSC) Key Stats
There are currently 7,585K shares outstanding in the company with a market cap of 4.96 million. Presently, the company’s annual sales total 2,230 K according to its annual income of -10,610 K. Last quarter, the company’s sales amounted to 180 K and its income totaled -1,970 K.
